KAKumarss Amini

Kumarss Amini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kumarss Amini has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mechanistic and clinical insights into a PmrB mutation driving colistin resistance and virulence in Acinetobacter baumannii

    by Kimia Bazyar, Pariya Jamali, Kiana Kalantar, Hasti Hedayatdoust, Kumarss Amini

    The global rise of colistin-resistant Acinetobacter baumannii (CRAB) is a critical health threat, particularly in the Middle East. The pmrB c.235T > A (p.Leu79Ile) mutation is frequently observed in clinical isolates, but its comprehensive characterization is lacking. In this multicenter study, 465 clinical A. baumannii isolates were collected from Iran (n = 378) and Iraq (n = 87) between January 2023 and June 2024. Colistin susceptibility was determined by broth microdilution, and the pmrCAB operon was sequenced. The structural impact of p.Leu79Ile was assessed via 200-ns molecular dynamics simulations. Functional consequences were evaluated using lipid A profiling, biofilm assays, serum resistance, and a murine pneumonia model. Phylogeographic analysis and a LASSO-regularized logistic regression model for 30-day mortality prediction were performed. Colistin resistance was detected in 47.8% of isolates, with 94.2% of resistant isolates harboring pmrCAB mutations; c.235T > A was predominant (76.8%). Simulations indicated that Leu79Ile stabilizes the active conformation of PmrB (ΔΔG = -3.8 kcal/mol), increasing the root mean square deviation (RMSD; 4.7 Å vs. 2.3 Å) and altering protein dynamics. This correlated with a 1.93-fold increase in pEtN-modified lipid A and a strong inverse correlation with colistin MIC (ρ = -0.89). Mutant isolates exhibited enhanced biofilm formation (2.3-fold), serum survival (47.6% increase), and murine mortality (70% vs. 30%). Phylogenetics identified a dominant ST848-bla ~ OXA-23~^+^ clone emerging around 2016 (95% HPD: 2015–2017), with evidence of Iran-Iraq cross-border transmission. The mortality prediction model (predictors: age > 65, CCI > 3, ventilation, shock, c.235T > A, ST848) achieved an AUC = 0.87 in validation. This study suggests the pmrB c.235T > A mutation confers a dual phenotype of colistin resistance and hypervirulence, driven by structural stabilization of PmrB within an expanding regional clone.


  • 10.69923/zz2fc132

    by Kumarss Amini, Alaauldeen Alsaedy

    Patients with systemic lupus erythematosus (SLE) are at great risk of bacterial infection because of immune system dysregulation and immunosuppressive treatment. Urinary tract and bloodstream infections are some of the most frequent complications, with high morbidity. The objective of this study was to determine the etiological agents defined and associated with urine and blood samples of patients with SLE and characterize them. A total of 110 urine and 8 blood samples were taken from patients with SLE who appeared at the hospital between March and August 2024. Cultures were handled according to standard microbiological methods, and bacterial strains were identified using Gram staining, biochemistry techniques, and VITEK $4 automated equipment. Blood samples: Gram-positive had a marginal predominance (50%), and Escherichia coli 3 (37.5%) was the commonest isolate, followed by Staphylococcus aureus 2 (25%), K pneumoniae 1 (12.5%), P aeruginosa 1 (12.5%), and Enterococcus faecalis 1 (12.5%). Conclusion: The epidemiology of both UTIs and BSIs, whether about Gram status or species, is mixed, with Escherichia coli and Staphylococcus aureus as the most common overall isolates among SLE patients. Prompt identification and optimal antibiotic treatment are important for minimizing morbidity and preventing major complications in this immunocompromised population.

  • Assessment of the Antimicrobial Efficacy of a Novel Peptide Against Porphyromonas gingivalis: An in Silico and in Vitro Investigation

    by Maryam Kiani Golshoui, Saeed Hemmatzadeh, Mohammad Sadegh Ghalyanchi Langeroudi, Kaveh Bazyar, Parisa Bonyadi, Ali Shivaee, Kumarss Amini, Behrooz Sadeghi Kalani


  • Recent advances in monoclonal antibody development for treatment of B-cell acute lymphoblastic leukemia

    by Hamideh Kamalloo, Mahnaz Fathi, Sobhan Bavandi, Fereshteh Asadi, Sheida Janati, Kumars Amini

    Monoclonal antibody (mAb)-based therapies targeting CD19, CD20, and CD22 have revolutionized B-ALL treatment, offering precision and reduced systemic toxicity by engaging immune mechanisms to eliminate leukemic cells. This review synthesizes literature from PubMed, Web of Science, and ClinicalTrials.gov (2000-2024), focusing on clinical outcomes and resistance mechanisms. Bispecific T-cell engagers (e.g. blinatumomab) and CD22-directed antibody-drug conjugates (e.g. inotuzumab ozogamicin) demonstrate robust efficacy in relapsed/refractory disease. Advances in antibody engineering, such as Fc optimization, nanobodies, and humanization, enhance tumor targeting and therapeutic safety. Persistent challenges include antigen escape, stromal-mediated resistance, and treatment-related toxicities. Combinatorial approaches integrating mAbs with CAR-T cells or checkpoint inhibitors show promise in overcoming resistance pathways. Emerging technologies like artificial intelligence and deep learning are transforming antibody design by predicting epitope binding, enabling de novo protein engineering, and streamlining affinity maturation. These innovations accelerate the development of next-generation therapies, underscoring the evolving potential of precision immunotherapy of B-ALL.


  • Open Access

    Molecular Characteristics and Pattern of Antibiotic Resistance of Common Escherichia coli Pathotypes Isolated From Wastewater of Slaughterhouses

    by Reihaneh Shahri, Akram Sadat Tabatabaee Bafroee, Kumars Amini

    Background: Wastewater from slaughterhouses serves as a reservoir for various Escherichia coli pathotypes, including enterotoxigenic (ETEC), enteropathogenic (EPEC), and enterohemorrhagic (EHEC) strains, which pose significant public health risks. This study aimed to isolate and molecularly identify common E. coli pathotypes in slaughterhouse wastewater and assess their antibiotic resistance patterns. Methods: A total of 58 E. coli isolates were collected from wastewater samples at local slaughterhouses. The isolates were subjected to molecular identification using a polymerase chain reaction targeting specific virulence genes associated with E. coli pathotypes. Antibiotic susceptibility testing was performed using the disk diffusion method against commonly used antibiotics. Results: The analysis of virulence genes in E. coli isolates revealed significant insights into the pathogenicity and potential health risks associated with these bacteria. A total of 58 isolates were analyzed for the presence of virulence genes. Among these, 20 (34.4%) were positive for the eae gene (EPEC), 5 (8.6%) for stx1 + stx2 (EHEC), and 4 (6.8%) for estA2-4 (ETEC). No isolates were positive for the elt gene. Additionally, 29 isolates (50.2%) did not carry any of the targeted virulence genes (eae, stx1 + stx2, estA2-4, or elt). The antibiotic resistance profile of E. coli isolates demonstrated significant resistance rates to commonly consumed antibiotics. Among the 58 isolates, resistance was observed to streptomycin (63.7%), kanamycin (39.6%), imipenem (51.7%), and notably erythromycin (100%). Additionally, 92% of virulence gene-positive isolates were multidrug-resistant, with four isolates exhibiting extensive resistance to all tested antibiotics. Conclusion: The findings highlight the prevalence of pathogenic E. coli strains in slaughterhouse wastewater and their resistance to multiple antibiotics, underscoring the potential health risks they pose and the need for effective management strategies to mitigate their impact on public health.

  • Open Access

    THE EFFECT OF LACTOCOCCUS LACTIS (+NIS) PROBIOTIC LYSATE ON THE EXPRESSION OF ANTI-APOPTOTIC BAX AND BCL-2 GENES IN KIDNEY CANCER CELL LINE

    by Kumarss Amini, Hamed Azadifar

    Background & Aims: Today, Lactococcus lactis bacteria play a key role as a probiotic in the treatment and prevention of cancer. Additionally, bacteriocins-producing strains of Lactococcus lactis are able to inhibit the growth of a wide range of bacteria, especially antibiotic-resistant strains. The aim of the present study was to investigate the effects ...

  • Open Access

    Maternal and filial consumption of probiotics protects from acute stress-induced anxiety and loss of benevolent gut microbes

    by Abdulazeez Kadhim Wali, Hamid Reza Mohajerani, Kumarss Amini

    The study aimed to determine the effects of probiotic consumption during pregnancy and lactation and post-weaning on acute stress-induced anxiety and gut beneficial microbiota of the female offspring mice.The female offspring mice were divided into several groups: intact, control (only stressed), PBS/dam (dams gavaged with PBS), PRO/dam (dams gavaged with probiotics), PRO/dam+off (both dams and offspring gavaged with probiotics), and PBS/dam+off (both dams and offspring gavaged with PBS)The probiotics chosen are mainly L. rhamnosus, B.breve, and B. longum (108 CFU/ml). Foot shock stress will be applied for one hour on the 43rd day after birth. Behavioral tests were conducted using the open field and elevated plus-maze. Corticosterone was measured by ELISA kit, and intestinal microflora with qPCR.The data showed that PRO/dam+off had more entries into open arms compared to the control group and decreased move distance and time spent in closed arms compared to the control group. However, there was no significant difference between the PRO/dam group and the control group. In the open field test, the control group spent less time in the inner zone compared to the intact group and in PRO/dam+off group. Corticosterone hormone was increased in the control group and was decreased in the PRO/dam+off. Bifidobacteria and Lactobacilli decreased in the control group in comparison to the intact group, and in the PRO/dam+off group increased compared with other groups. Maternal and filial supplementation with a multi-strain probiotic mixture increased levels of beneficial bacteria and reduced stress-induced anxiety in mice.


  • Evaluation of probiotic bifidobacteria strains from Iranian traditional dairy products for their anti-hyperlipidemic potential

    by Nasim Afshar, Kumarss Amini, Hamidreza Mohajerani, Sasan Saki

    This study investigated the therapeutic potential of probiotic bifidobacteria, isolated from Iranian fermented dairy products, in a hyperlipidemic animal model. Bifidobacterium strains were extracted from traditional dairy samples and screened using physiological and phenotypic examinations, 16S rRNA analysis, and probiotic properties such as tolerance to gastrointestinal juice, antimicrobial activity, and antibiotic susceptibility. The ability of the screened bifidobacteria to reduce serum and liver lipids in vivo was tested using male Wistar rats. Six strains of bifidobacteria were isolated from traditional Iranian fermented dairy. These strains showed promising in vitro activity in lowering triglyceride and cholesterol, tolerance to simulated gastrointestinal juice, the ability to adhere to Caco-2 cells, acceptable antibiotic susceptibility, and a broad spectrum of antibacterial activity. The diet supplemented with isolated bifidobacteria significantly reduced serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), liver tissue lipid levels, and hepatic enzymes in animals when compared to a high-fat diet without strains (p < 0.01). Additionally, the potential probiotic-supplemented diet significantly increased bile acid excretion in the feces and upregulated hepatic CYP7A1 expression levels (p < 0.05), while NPC1L1, ACAT2, and MTP gene expressions in small intestinal cells were downregulated (p < 0.05). Bifidobacteria isolated from Iranian traditional dairy showed potential for use in the production of fermented foods that have hypolipemic activity in the host.


  • Investigating the effects of zinc oxide and titanium dioxide nanoparticles on the formation of biofilm and persister cells in Klebsiella pneumoniae

    by Aisouda Pourmehdiabadi, Mojgan Sarabi Nobakht, Behdad Hajjam Balajorshari, Mohammadreza Rezaei Yazdi, Kumarss Amini

    The biofilm formation in klebsiella pneumoniae isolates poses a significant problem as it can result in treatment failure and the development of chronic infections. These biofilms act as protective barriers, rendering the bacteria resistant to antibiotics. Additionally, persister cells, which make up a small fraction of the bacterial population, have the ability to enter a dormant state after treatment with high doses of antibiotics. These persister cells play a crucial role in the high level of biofilm‐mediated tolerance to antibiotics. The present study aimed to investigate the impact of Zinc oxide (ZnO) and titanium dioxide (TiO2) nanoparticles on the formation of biofilm and persister cells in K. pneumoniae. The minimum inhibitory concentration (MIC) of colistin in K. pneumoniae ATCC 13883 was determined using the microdilution method. The formation of persister cells was evaluated by introducing sub‐MIC of colistin. Subsequently, the MIC of ZnO NPs and TiO2 NPs in these persister cells was assessed using the microdilution method. Furthermore, the effects of nanoparticles on the expression levels of biofilm‐associated genes were analyzed using real‐time polymer chain reaction (PCR). The MIC values for colistin, ZnO, and TiO2 were determined at 2, 12.5, and 6.25 μg/mL, respectively. In the presence of nanoparticles, biofilm formation decreased. Real‐time PCR results showed the messenger RNA (mRNA) level of mrkH and fimH were decreased and the expression of luxS and mazF were increased. Biofilm formation of K. pneumoniae ATCC 1383 was inhibited in response to nanoparticles. According to the results of the present study use of nanoparticles may help control multidrug‐resistant (MDR) infections in hospitalized patients.


  • Open Access

    Antiproliferative potential of Lactobacillus casei supernatant against MCF-7 breast cancer and HT-29 colorectal cancer cell lines

    by Zahra Haji Mehdi Nouri, Farzaneh Tafvizi, Kumarss Amini, Nooshin Khandandezfoli, Babak Kheirkhah

    This study aimed to investigate the induction of cytotoxicity in colon (HT-29) and breast (MCF-7) cancer cells after treatment with the supernatant of Lactobacillus casei bacteria, as well as changes in the expression of genes involved in apoptosis in vitro. After extracting the bacterial supernatant, the MTT test was performed ...